This Herpes Cure is Proving to Work Better than its Predecessors
AiCuris' candidate pritelivir has shown to perform better than current standard antiviral treatments against genital…
Keep up to date with the latest advances in medical biotechnology and discover how biotech is transforming and improving the way we treat disease.
AiCuris' candidate pritelivir has shown to perform better than current standard antiviral treatments against genital…
Wilex is selling Telix Pharmaceuticals its radiolabeled antibody for cancer applications, Redectane, to focus on…
Merck will use Palantir's big data software to improve drug development and patient services, starting…
Horizon Discovery now has full access to CRISPR technology and will develop an automated gene…
UPDATE (12/01/2017): J&J and Actelion have reportedly settled on a price: $260 (€245) per share,…
Ablynx has treated its first patient in a new trial targeting RSV infections, the main…
Luxendo has raised €8M to start international sales of its unique microscopy technology aiming to take over…
Novartis is initiating Phase II trials with an antibody licensed from German biotech MorphoSys that…
Money doesn't guarantee success, even if it's heavy investment from the likes of the Bill…
Merck is diversifying its oncology portfolio with four new programs licensed from Vertex Pharmaceuticals, including…
Researchers from the UK have described a new treatment for cavities that could get rid…
Qiagen is entering the promising field of multi-omics data analysis with the acquisition of a…